Trivant Custom Portfolio Group, LLC Mannkind Corp Transaction History
Trivant Custom Portfolio Group, LLC
- $173 Billion
- Q3 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 150 shares of MNKD stock, worth $1,063. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$1,063
Previous $783,000
20.56%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MNKD
# of Institutions
229Shares Held
133MCall Options Held
1.43MPut Options Held
849K-
Black Rock Inc. New York, NY22.6MShares$160 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$109 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$71.5 Million5.97% of portfolio
-
State Street Corp Boston, MA9.56MShares$67.8 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.76MShares$62.1 Million0.62% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.82B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...